Gumaod, Arlene .

HRN: 23-64-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2023
CEFUROXIME 1.5GM (VIAL)
08/29/2023
08/31/2023
IV
1.5
Q8
PROM; Breech
Waiting Final Action 
08/29/2023
CEFUROXIME 1.5GM (VIAL)
08/29/2023
08/31/2023
IV
1.5
Q8
Sp LTCS
Waiting Final Action 
08/29/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/29/2023
08/30/2023
IV
500
Q8
Sp LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: